Phase I clinical trial data of biopharma companies in 2022

Willets Point Phase II EDC - Economic Development Corporation for NYC — Co Brooklyn

STUDIO ZEWDE – VITAL BROOKLYN: KINGSBORO PUBLIC OPEN SPACE Phase I • 330,221 GSF • 2 Supportive Housing and Family buildings

indibet app install Apellis Pharmaceuticals Inc , of Waltham, Mass APL-9, Targeted C3 therapy BDC-1001, Immune-stimulating antibody conjugate comprising HER2

vital brooklyn bdc phase ib c3 A Phase I Environmental Site Assessment and Phase II VITAL BROOKLYN